FDA loosens restrictions on remdesivir

The Food and Drug Administration further expanded the authorized use of remdesivir for treating COVID-19 patients, the agency announced Friday. Now, remdesivir can be used for all admitted COVID-19 patients, confirmed or suspected, whether on oxygen, off oxygen or intubated.

This is a departure from the previous policy that restricted such treatment to those who required oxygen.